Alprazolam tablets are used for the management of anxiety disorder, short-term relief of anxiety symptoms and treatment of panic disorder with or without agoraphobia.
The affected lot, 8082708, which comes as a bottle of 500 pills, was distributed in the U.S. between July 2019 and August 2019.
Mylan has not received any adverse event reports related to the affected lot.
More articles on pharmacy:
Novant Health leaders talk Walgreens partnership goals for 2020
Sanofi recalls heartburn drug over cancer risks
Centura Health opens retail pharmacy
Mylan is recalling one lot of its generic version of Xanax, called alprazolam tablets, due to the potential presence of a foreign substance.
Alprazolam tablets are used for the management of anxiety disorder, short-term relief of anxiety symptoms and treatment of panic disorder with or without agoraphobia.
The affected lot, 8082708, which comes as a bottle of 500 pills, was distributed in the U.S. between July 2019 and August 2019.
Mylan has not received any adverse event reports related to the affected lot.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.